Your Yourlocation: Home > Efficacy of tiotropium bromide(136310-93-5) in the treatment of chronic obstructive pulmonary disease

To observe the clinical effect of tiotropium bromide(136310-93-5) inhalation in the treatment of stable chronic obstructive pulmonary disease(COPD).

Methods: 67 patients with COPD were randomly divided into two groups. The control group received oral theophylline sustained release tablets (100 mg twice daily) and was inhaled with β2 agonists. The treatment group received a single dose of inhaled tiotropium bromide(136310-93-5) 18μg, daily 1 suction. The changes of clinical symptoms and signs were compared between the two groups before and 3 months after treatment, pulmonary function, 6 min walking distance (6MWD) and quality of life score were detected. Results: The symptoms and signs of the treatment group were significantly different from those of the control group (P <0.05). The lung function, 6MWD and quality of life scores were significantly higher than those in the control group was statistically significant(P <0.05).

Conclusion: Tiotropium bromide(136310-93-5) can significantly improve the clinical symptoms and signs of lung cancer in patients with stable COPD, improve the quality of life.

Address: TEL:0531-82375879 Tiotropium Bromide
© Copyright(C)2014 JINAN DEXINJIA BIO & TECH CO., LTD All Rights Reserved